Afirma GEC is a gene profiling method able to determine the benign nature of a thyroid nodule and to avoid surgery for the patient with indeterminate thyroid nodule (THY3, Bethesda III or IV).
Thyroid needle aspiration (Fine Needle Aspiration, FNA) allows, in most cases, a definitive diagnosis about thyroid nodule nature. Therefore, a thyroid lesion can be classified as ...
Afirma GSC X Atlas represents the most advanced method currently available worldwide for the genomic analysis of indeterminate thyroid nodules (Thy 3a, Thy3f, Bethesda III (AUS/FLUS), Bethesda IV).
AFIRMA GSC AND AFIRMA GEC – DIFFERENCES
Continua →
In the field of indeterminate thyroide nodules are currently available complete and advanced molecular genetic methods. Among these, Afirma, produced by Veracyte, San Francisco (U.S.A.), represents the one able to determine, with higher reliability and before the surgical intervention, if a thy3 indeterminate thyroid nodule is really benign.
Developed in the United ...
Utilizziamo i cookie per offrirti la migliore esperienza online. Cliccando sul tasto Accetta ci aiuterai a lavorare meglio in conformità con la nostra politica sui cookie.